Are there any changes to capital allocation, debt repayment, or dividend policy in response to the recent results?

No explicit policy shift was disclosed – the 3Q 25 release and the accompanying Form 10‑Q contain only the headline financials (revenues, EPS, non‑GAAP EPS, impairments and operating cash flow) and do not announce any new capital‑allocation plan, debt‑repayment schedule, or dividend adjustment. RCI’s management simply reported that operating cash generation slipped to $13.8 M (vs $15.8 M a year ago) and that impairments fell to $2.3 M (down from $18.3 M), leaving the free‑cash balance unchanged from the prior quarter.

What this means for the market – in the absence of a declared dividend or buy‑back, the stock will continue to be priced on the fundamentals of a modest cash‑flow decline and a contraction in top‑line revenue (‑5 %). Traders should therefore focus on the price‑action and balance‑sheet health rather than expecting a near‑term payout or accelerated debt reduction. The lack of a clear capital‑allocation signal keeps the upside/downside narrative driven by technical factors: the share is still below its 52‑week high, the 20‑day moving average is turning down, and the RSI is hovering in the 40‑45 range, suggesting a short‑to‑neutral stance until the company issues a concrete guidance on capital use or dividend policy.